Opexa Therapeutics Inc (NASDAQ:OPXA)

Data as of Jan 27
 -0.005 / -0.64%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Opexa Therapeutics, Inc. is a biopharmaceutical company developing personalized immunotherapy with the potential to treat major illnesses, including multiple sclerosis. This therapy is based on T-cell technology. The company's therapy candidate, Tcelna, is a personalized T-cell immunotherapy for the treatment of secondary progressive multiple sclerosis. The company was founded in 2004 and is headquartered in The Woodlands, TX.

Contact Information

Opexa Therapeutics, Inc.
2635 Technology Forest Boulevard
The Woodlands Texas 77381
P:(281) 775-0600
Investor Relations:



Individual stakeholders3.91%
Mutual fund holders2.52%
Other institutional2.20%

Top Executives

Neil K. WarmaPresident, Chief Executive Officer & Director
Donna R. RillChief Development Officer & SVP-Operations
Karthik RadhakrishnanChief Financial Officer
Dawn McGuireChief Medical Officer
Donald HealeyChief Scientific Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.